STING activation reduces graft-versus-host disease in a mouse model
MUSC Hollings Cancer Center researcher Yongxia Wu, Ph.D., identified a new target molecule in the fight against graft-versus-host disease (GVHD). Bone marrow transplant, a treatment for certain blood cancers, is accompanied ...
Feb 12, 2021
0
24